Problems with the change in generics: Justified complaints or only imagination of the patients? Probleme beim Generikawechsel Berechtigte Klagen oder nur Einbildung der Patienten?

Weitzel J.; Wünsch A.; Erzkamp S.; Rose O.; Langer K. (2023)

In: Deutsche Apotheker-Zeitung, 163(2).

Research article (journal)

Lipoprotein imitating nanoparticles targeting LRP1 – A promising pathway to cross the blood-brain barrier?

Laabs, M.; Mulac, D.; Wünsch, A.; Langer, K. (2023)

In: 22. Barriere- und Transporter-Days, Bad Herrenalb, Germany.

Abstract in digital collection (conference)

Different strategies to formulate flurbiprofen in PEGylated lipid-polymer hybrid nanoparticles carrying it across the blood-brain barrier.

Laabs, M.; Mulac, D.; Langer, K.; Wünsch, A. (2022)

In: DPhG Annual Meeting, Marburg, Germany.

Abstract in digital collection (conference)

Nanoparticles inspired by lipoproteins: A lecithin stabilized and ApoE functionalized carrier system to overcome the blood-brain barrier.

Wünsch A., Mulac D., Langer K. (2021)

In: DPhG Annual Meeting, Leipzig online.

Abstract in digital collection (conference)

Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.

Wünsch A., Mulac D., Langer K. (2020)

In: ((Bitte Journal prüfen)), 589.

Research article (journal)

Publications

Contact

Top-Links

Natural or synthetic? Investigation of different phospholipids as coating material for LNPs. Laabs, M.; Mulac, D.; Wünsch, A.; Langer, K. (2024) In: 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Wien, Austria. Poster
Problems with the change in generics: Justified complaints or only imagination of the patients? Probleme beim Generikawechsel Berechtigte Klagen oder nur Einbildung der Patienten? Weitzel J.; Wünsch A.; Erzkamp S.; Rose O.; Langer K. (2023) In: Deutsche Apotheker-Zeitung, 163(2). Research article (journal)
New lipid-polymer hybrid nanoparticles loaded with flurbiprofenaxetil and coated with apolipoprotein E – A game changer in Alzheimer´s treatment? Laabs, M.; Mulac, D.; Wünsch, A.; Langer, K. (2023) In: 4th European Conference on Pharmaceutics, Marseille, France. Abstract in digital collection (conference)
Lipoprotein imitating nanoparticles targeting LRP1 – A promising pathway to cross the blood-brain barrier? Laabs, M.; Mulac, D.; Wünsch, A.; Langer, K. (2023) In: 22. Barriere- und Transporter-Days, Bad Herrenalb, Germany. Abstract in digital collection (conference)
Nature as a model: Using phospholipids as coating material for lipid nanoparticles to imitate natural lipoproteins. Laabs, M.; Mulac, D.; Wünsch, A.; Langer, K. (2023) In: DPhG Annual Meeting, Tübingen, Germany. Abstract in digital collection (conference)
Different strategies to formulate flurbiprofen in PEGylated lipid-polymer hybrid nanoparticles carrying it across the blood-brain barrier. Laabs, M.; Mulac, D.; Langer, K.; Wünsch, A. (2022) In: DPhG Annual Meeting, Marburg, Germany. Abstract in digital collection (conference)
Lecithin coating as universal stabilization and functionalization strategy for nanosized drug carriers to overcome the blood-brain barrier. Wünsch A., Mulac D., Langer K. (2021) In: ((Bitte Journal prüfen)), 593. Research article (journal)
Nanoparticles inspired by lipoproteins: A lecithin stabilized and ApoE functionalized carrier system to overcome the blood-brain barrier. Wünsch A., Mulac D., Langer K. (2021) In: DPhG Annual Meeting, Leipzig online. Abstract in digital collection (conference)
ApoE-modified Lipid Nanoparticles Enclosing Different Core Variations to Overcome the Blood-Brain Barrier. Wünsch A., Mulac D., Langer K. (2021) In: CRS Virtual Annual Meeting, online. Abstract in digital collection (conference)
Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier. Wünsch A., Mulac D., Langer K. (2020) In: ((Bitte Journal prüfen)), 589. Research article (journal)